Rolditamig
Based on 1 Customer Validation
Rolditamig (TQB2102 Antibody) is a recombinant humanized anti-human epidermal growth factor receptor 2 (HER2) antibody. Rolditamig can be conjugated with an enzyme-cleavable linker and a topoisomerase I inhibitor to form the ADC TQB2102. Rolditamig is applicable to research on solid tumors such as HER2-positive breast cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 95.26%
- No. CAS: 3038136-62-5
- Peso molecular:124.8 kDa
-
Almacenamiento:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas EGFR
More
Actividad biológica
Descripciòn
Isotype
immunoglobulin (H-gamma1_L-kappa)_scFvhk-G1(h-CH2-CH3)
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[1]|
HER2 |
Gene ID
Accession
Target
ERBB2/HER2/CD340
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
G1-kappa_scFv-HEAVY-KAPPA-h-CH2-CH3
Aplicación
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized HER2/CD340 Protein, Human (HEK293, HY-P73094) can bind Rolditamig, The ED50 for this effect is 3.572 ng/mL.
Chemical Information
-
No. CAS 3038136-62-5
-
Appearance Liquid
-
Peso molecular 124.8 kDa
-
Color Colorless to off-white
-
SMILES
[Rolditamig]
-
Synonyms
TQB2102 Antibody
-
Envío
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
Ficha de datos (272 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Rolditamig
- 3038136-62-5
- TQB2102 Antibody
- ADC Antibodies
- EGFR
- HER2 low metastatic breast cancer
- human epidermal growth factor receptor 2
- HER2 positive gastric cancer
- extracellular domains II
- extracellular domains IV
- HER2 3+ colorectal cancer
- advanced solid tumors
- HER2
- HER2 positive metastatic breast cancer
- Inhibitor
- inhibitor
- inhibit